Centro simplifies structure to manage debthttp://www.theaustralian.news.com.au/story/0,,23885710-25658,00.html?from=public_rss
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%